Xconomy: Agenda: Big Insight—Making Sense of Big Data in Seattle


	AGENDA

	1:00 – 2:00	Registration
	2:00 – 2:05	Welcome Benjamin Romano, Senior Editor, Xconomy Seattle
	2:05 – 2:30	Opening Keynote Jeremy Jaech, CEO, SNUPI Technologies
	2:30 – 2:45	Investor-Entrepreneur Story: GraphLab Matt McIlwain Managing Partner, Madrona Venture Group Carlos Guestrin, CEO, GraphLab
	2:45 – 3:20	Big data tools and platforms: Insight for all Robert Bismuth, VP of Business Development, Pivotal Jock Mackinlay, VP of Visual Analysis, Tableau Software John Slitz, CEO, SpaceCurve Peter Godman, CEO, Qumulo Kristina Kerr Bergman, Partner, Ignition Partners (moderator)
	3:20 – 3:25	Burst Presentation Steve Sliwa, CEO, Seeq Corp
	3:25 – 3:55	Networking Break
	3:55 – 4:20	Keynote Stan Humphries, Chief Economist, Zillow
	4:20 – 4:55	Big data applications: Use your imagination Bryan Mistele, CEO, INRIX Kevin Merritt, CEO, Socrata Olly Downs, SVP, Data Science, Globys Emily McReynolds, Managing Fellow, UW Tech Policy Lab (moderator)
	4:55 – 5:00	Burst Presentation Stephen Purpura, CEO, Context Relevant
	5:00 – 5:35	Data-driven science: New arrows in the researcher’s quiver Roger Barga, Principal Group Program Manager, Microsoft Research Joseph Hellerstein, Manager of Computational Discovery, Google Bill Pike, Visual Analytics Group, Pacific Northwest National Laboratory Ed Lazowska, Bill & Melinda Gates Chair in Computer Science & Engineering; Founding Director, eScience Institute, University of Washington (moderator)
	5:35 – 5:55	Closing Keynote Oren Etzioni, Executive Director, Allen Institute for Artificial Intelligence
	5:55 – 6:00	Thank you and Closing Benjamin Romano, Senior Editor, Xconomy Seattle
	6:00 – 7:00	Networking Reception
	7:00	After-party hosted by IDA Ireland

REGISTER NOW: xconomyforum63.eventbrite.com

Xconomy Seattle

Fetch Rewards Grabs $25M, Plans to Double Staff as Growth Accelerates

Nuance Spinout Cerence Vies With Tech Giants in Voice-AI for Auto

Can Ford’s Self-Driving Car Business Improve Austin’s Traffic Woes?

John Halamka, Livongo Health & AI Progress at X·CON on Oct. 22

As More Grocers Embrace Tech, Swiftly Snags $15M to Launch in Seattle

Bio Roundup: Coronavirus Concerns, Sarepta’s CRL, Eye Drug OK’d & More

Epizyme’s Soft Tissue Cancer Drug Granted Speedy FDA Approval

After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune

FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs

Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment

Epizyme’s Soft Tissue Cancer Drug Granted Speedy FDA Approval

ArcherDX Raises $55M to Help Physicians Pick Best Cancer Therapies

Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal

Eli Lilly Gets Skin in the Eczema Game With $1.1B Deal for Dermira

Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits

Dova Pharmaceuticals Agrees to Sobi Acquisition, Shares Jump 38%

CEOs of Women’s Health Companies Fight to Open Investment Floodgates

Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers

A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns

Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing

AI Can Unlock Health Data's Potential, But Access Is Still Difficult

Amazon Invests in Foodista

FDA Green Lights Sight Diagnostics’ Finger-Prick Blood Test

Healthcare AI Tech is Here, Now We Must Learn to Manage the Data

Partner or Die: How to Succeed Even After the Digital Health Hype Quiets Down

Alan Sachs

Brooks Bell

Andy Liu

Brad Bernthal

Ben Elowitz

Elizabeth Hagerman

Dane Stangler

Art Pappas

Xcelerating Life Sciences San Diego

Underwriters and Partners

Xconomy on Demand

Did you miss something? Don't despair…

Underwriters and Partners

Connect with Xconomy

Xconomy on Demand